Mir-451 inhibits proliferation and migration of non-small cell lung cancer cells via targeting LKB1/AMPK
Mir-451 inhibits proliferation and migration of non-small cell lung cancer cells via targeting LKB1/AMPK
复制标题
DOI:
10.26355/eurrev_201908_18657
复制
发表时间:
2019-01-01
影响因子:
3.3
通讯作者:
Sheng, Y. -L.
中科院分区:
文献类型:
--
作者:
Liu, Y.;Li, H.;Sheng, Y. -L.
OBJECTIVE: To discuss the influence of micro ribonucleic acid (miR)-451 on cell proliferation and apoptosis of non-small cell lung cancer (NSCLC) by regulating liver kinase B1 (LKB1) signals and activating adenosine monophosphate-activated protein kinase (AMPK).MATERIALS AND METHODS: Lung cancer A549 cells were divided into control group, miR451 mimic group, and miR-451 inhibitor group. The cell proliferation and migration ability, as well as the expression of LKB1 and AMPK in the three groups, were determined via Reverse Transcription-Polymerase Chain Reaction (RT-PCR), transwell assay, and cell counting kit-8 (CCK8) assay, respectively.RESULTS: Compared with that in control group, the number of migrating cells evidently declined in miR-451 mimic group, while that in miR-451 inhibitor group was significantly increased, and the differences were statistically significant (p < 0.05). At 7 d of cell culture, the cell proliferation ability in miR-451 mimic group was higher than that in control group, while it was higher in control group than that in miR451 mimic group, and there were significant differences among the three groups (p < 0.05). The expression of LKB1 and AMPK was significantly decreased in miR-451 mimic group compared with that in miR-451 inhibitor group and control group, and the differences had statistical significance (p < 0.05). T he d ifferences i n a ctivities of LKB1 and AMPK between miR-451 inhibitor group and control group were not significant ( p > 0.05).CONCLUSIONS: LKB1/AMPK can be involved in the cell metabolism of NSCLC and miR-451 is negatively correlated with LKB1/AMPK. Therefore, miR-451 may inhibit cell proliferation and migration of NSCLC via regulating LKB1/AMPK.